Helmi Muhd Alwi Muhd, Hussain Suhaimi
Paediatric Department, Kulliyyah of Medicine, International Islamic University Malaysia.
Paediatric Department, School of Medical Sciences, University Sains Malaysia.
J ASEAN Fed Endocr Soc. 2020;35(1):125-128. doi: 10.15605/jafes.035.01.22. Epub 2020 Apr 25.
Developmental delay, Epilepsy and Neonatal Diabetes (DEND) syndrome is the most severe form of Permanent Neonatal Diabetes with KCNJ11 gene mutation which accounts for most of the cases. We report the first DEND syndrome in Malaysia with heterozygous missense mutation Q52R at KCNJ11 (Kir6.2) gene with delayed presentation beyond 6 months of age and failure to transition to glibenclamide. This report signifies the phenotypical variability among patients with the same genetic mutation and the different response to treatment.
发育迟缓、癫痫与新生儿糖尿病(DEND)综合征是永久性新生儿糖尿病最严重的形式,由KCNJ11基因突变引起,该突变占大多数病例。我们报告了马来西亚首例DEND综合征,其KCNJ11(Kir6.2)基因存在杂合错义突变Q52R,发病延迟超过6个月,且无法转换为使用格列本脲治疗。本报告表明了具有相同基因突变的患者之间存在表型变异性以及对治疗的不同反应。